Critical Care Medicine
5 November, 2026
Crit Care. 2026 Aug 6;30(1):569. doi: 10.1186/s13054-026-06239-8.
ABSTRACT
BACKGROUND: Physiological alterations in patients with sepsis and trauma can influence antibiotic clearance, yet reliable predictors remain poorly defined. We aimed to investigate the determinants of piperacillin and cefazolin clearance in these populations to identify bedside indicators of subtherapeutic exposure.
METHODS: Prospective physiological and pharmacokinetic study in patients receiving piperacillin/tazobactam for sepsis or prophylactic cefazolin post-trauma. Patients also received intravenous sinistrin. Intensive pharmacokinetic sampling, cardiac output (CO) monitoring and four urinary creatinine clearance (uCLCR) measurements were performed. Data were analysed with non-compartmental pharmacokinetic methods, and linear and logistic regression.
RESULTS: We enrolled 49 septic and 28 trauma patients. Trauma patients were younger (33.5 vs. 46.5 years) and had higher uCLCR (155.5 vs. 107.5 mL/min). Linear regression identified that lower Sequential Organ Failure Assessment scores and an hyperdynamic state with higher CO and 2 and 8-h uCLCR were the strongest predictors of increased piperacillin total clearance; higher 2-h uCLCR and hypoalbuminemia were the main predictors for cefazolin total clearance. Sinistrin CL was a weak predictor. Logistic regression identified augmented renal clearance (8-h uCLCR > 130 mL/min) as the main risk factor for piperacillin subtherapeutic exposure (OR 10.9, p < 0.05), also when defined using the Cockcroft-Gault cut-off of 114.5 mL/min from ROC analysis.
CONCLUSIONS: In sepsis, low sickness severity and a hyperdynamic state with high cardiac output lead to increased uCLCR and high piperacillin clearance. In trauma, high cefazolin clearance occurs in the presence of an elevated uCLCR and hypoalbuminemia. These bedside physiological indicators, along with Cockcroft-Gault CLCR, may serve as early indicators of risk for subtherapeutic exposure.
PMID:42983577 | PMC:PMC13737850 | DOI:10.1186/s13054-026-06239-8
Critical Care
© 2026 Imedsource, All Rights Reserved
For unrestricted access to content and a seamless experience,
Complete your profile to help us deliver a more personalized experience.